Literature DB >> 21258230

Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.

Dandan Wu1, Jiachang Cai, Jin Liu.   

Abstract

OBJECTIVES: Carbapenem-resistant Klebsiella pneumoniae (CRKP) has been increasingly reported all over the world. In this study, we aimed to investigate the risk factors for the acquisition of nosocomial CRKP infections.
METHODS: We conducted a case-control study with data collected from thirty-nine patients with nosocomially acquired CRKP infection between July 2006 and July 2008. Controls were selected at a ratio of 1:2 from patients with nosocomial carbapenem-susceptible Klebsiella pneumoniae (CSKP) infection and were matched with CRKP cases for site of infection and the date of hospital admission (± within 5 days). T test, chi-square test, and logistic regression were used for statistical analysis.
RESULTS: Bivariable analysis showed that the age of the patients (P=0.038), days of hospital stay prior to isolation of Klebsiella pneumoniae (K. pneumoniae) (P=0.043), altered consciousness (P=0.007), intensive care unit (ICU) admission within two weeks (P=0.003), tracheal intubation (P=0.027), mechanical ventilation (P=0.009), number of changes in antibiotics≥4 (P=0.001), exposure to carbapenems (P = 0.002), exposure to fourth-generation cephalosporins (P=0.027), and exposure to piperacillin-tazobactams/cefoperazone-sulbactams (P=0.043) and glycopeptides (P=0.042) were related to CRKP infection. The multivariable analysis showed that ICU admission (within two weeks) [odds ratio (OR):4.68, 95% confidence intervals (CI):1.15-19.09, P=0.031], exposure to carbapenems (OR: 12.69, 95% CI: 2.09-77.10, P=0.006) and exposure to glycopeptides (OR: 3.57, 95% CI: 1.11-11.42, P=0.032) were independent risk factors for nosocomial CRKP infections.
CONCLUSION: Several factors are related to CRKP infections. ICU admission (within two weeks) or prior exposure to carbapenems or glycopeptides are independent risk factors for the acquisition of nosocomial CRKP infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258230     DOI: 10.1097/SMJ.0b013e318206063d

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  14 in total

1.  The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province, China.

Authors:  X Zhen; Y Chen; X Hu; P Dong; S Gu; Y Y Sheng; H Dong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-23       Impact factor: 3.267

2.  Carbapenem-Resistant Enterobacteriaceae Infections in Children.

Authors:  Kathleen Chiotos; Jennifer H Han; Pranita D Tamma
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

3.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study.

Authors:  Fethiye Akgul; Ilkay Bozkurt; Mustafa Sunbul; Saban Esen; Hakan Leblebicioglu
Journal:  Pathog Glob Health       Date:  2016-12-01       Impact factor: 2.894

5.  Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.

Authors:  Yang Jiao; Yanghua Qin; Jiajun Liu; Qiang Li; Yuchao Dong; Yan Shang; Yi Huang; Rui Liu
Journal:  Pathog Glob Health       Date:  2015-02-24       Impact factor: 2.894

6.  Outcomes and Risk Factors of Bloodstream Infections Caused by Carbapenem-Resistant and Non-Carbapenem-Resistant Klebsiella pneumoniae in China.

Authors:  Xiaoxue Liang; Ping Chen; Baoguo Deng; Feng-Hui Sun; Yongqiang Yang; Yanxian Yang; Ruowen He; Mingyang Qin; Yiping Wu; Fan Yang; Guo-Bao Tian; Min Dai
Journal:  Infect Drug Resist       Date:  2022-06-17       Impact factor: 4.177

7.  A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.

Authors:  Ana M Ocampo; Liang Chen; Astrid V Cienfuegos; Gustavo Roncancio; Kalyan D Chavda; Barry N Kreiswirth; J Natalia Jiménez
Journal:  Antimicrob Agents Chemother       Date:  2015-10-26       Impact factor: 5.191

Review 8.  Limiting and controlling carbapenem-resistant Klebsiella pneumoniae.

Authors:  Lisa Saidel-Odes; Abraham Borer
Journal:  Infect Drug Resist       Date:  2013-12-10       Impact factor: 4.003

9.  Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs.

Authors:  Aslıhan Candevir Ulu; Behice Kurtaran; Ayşe Seza Inal; Süheyla Kömür; Filiz Kibar; Hatice Yapıcı Çiçekdemir; Seval Bozkurt; Derya Gürel; Fatma Kılıç; Akgün Yaman; Hasan Salih Zeki Aksu; Yeşim Taşova
Journal:  Med Sci Monit       Date:  2015-01-17

10.  Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study.

Authors:  Viviana Gómez Rueda; John Jairo Zuleta Tobón
Journal:  Colomb Med (Cali)       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.